Skip to content
10-Q

Quarterly Report

GLOBAL IMMUNE TECHNOLOGIES INC.

0001144204-12-063629

← back to feed
Filed
Nov 19, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2011 · Oct 31, 2012 23.89M sh
Operating Cash Flow Q2 2011 · Sep 30, 2011 −$1.14M
Operating Cash Flow Q2 2011 · Sep 30, 2010 $0
Stockholders Equity Q2 2011 · Sep 30, 2011 −$865.3K
Current Liabilities Q2 2011 · Sep 30, 2011 $865.3K
Current Liabilities Q2 2011 · Mar 31, 2011 $850.3K
Sga Expense Q2 2011 · Sep 30, 2011 $333.89K
Sga Expense Q2 2011 · Sep 30, 2010 $0
Sga Expense Q2 2011 · Sep 30, 2010 $118
Net Income Q2 2011 · Sep 30, 2011 −$2.36M
Net Income Q2 2011 · Sep 30, 2010 −$7.5K
Net Income Q2 2011 · Sep 30, 2010 −$19.77K
Operating Income Q2 2011 · Sep 30, 2011 −$1.44M
Operating Income Q2 2011 · Sep 30, 2010 −$7.5K
Operating Income Q2 2011 · Sep 30, 2010 −$19.77K
Cash And Equivalents Q2 2011 · Sep 30, 2010 $0
Cash And Equivalents Q2 2011 · Mar 31, 2010 $0